<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Published reported of skin findings have continued to evolve since the COVID-19 pandemic began (
 <xref rid="t0005" ref-type="table">Table 1</xref>). A Chinese study claimed &lt;1% incidence of cutaneous manifestations, whereas an Italian cohort reported &gt;20%, suggesting presentational differences in subset populations (
 <xref rid="b0330" ref-type="bibr">Recalcati, 2020</xref>, 
 <xref rid="b0365" ref-type="bibr">Sachdeva et al., 2020</xref>, 
 <xref rid="b0400" ref-type="bibr">Tang et al., 2020</xref>). The manifestations ranged from maculopapular exanthems, petechial rashes, and pernio-like findings to vesicular lesions (
 <xref rid="b0025" ref-type="bibr">Bouaziz et al., 2020</xref>, 
 <xref rid="b0160" ref-type="bibr">Galván Casas et al., 2020</xref>, 
 <xref rid="b0280" ref-type="bibr">Manalo et al., 2020</xref>, 
 <xref rid="b0390" ref-type="bibr">Tammaro et al., 2020</xref>). Of note, many cases occurred in the child and adolescent populations, such as the pernio-like lesions of the feet dubbed “COVID toes” (
 <xref rid="b0230" ref-type="bibr">Kolivras et al., 2020</xref>, 
 <xref rid="b0240" ref-type="bibr">Landa et al., 2020</xref>, 
 <xref rid="b0335" ref-type="bibr">Recalcati et al., 2020</xref>, 
 <xref rid="b0330" ref-type="bibr">Recalcati, 2020</xref>). These skin presentations have the potential to confound an early diagnosis of COVID-19 because they can simulate other infections (
 <xref rid="b0265" ref-type="bibr">Lu et al., 2020</xref>). One such case was presented as a patient with a petechial rash who was given an original diagnosis of Dengue fever that was later confirmed to be COVID-19 (
 <xref rid="b0220" ref-type="bibr">Joob and Wiwanitkit, 2020</xref>, 
 <xref rid="b0310" ref-type="bibr">Mungmungpuntipantip and Wiwanitkit, 2020</xref>).
</p>
